JPRN-UMIN000009524
Completed
Phase 3
A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalities - A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalities
agoya University Graduate School of Medicine, Department of Pediatrics0 sites240 target enrollmentDecember 17, 2012
ConditionsKawasaki disease
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Kawasaki disease
- Sponsor
- agoya University Graduate School of Medicine, Department of Pediatrics
- Enrollment
- 240
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients with past histories of Kawasaki disease 2\.Patients diagnosed as Kawasaki disease on the ninth day of illness or later. 3\.Kawasaki disease patients with coronary artery lesions before treatment 4\.Kawasaki disease patients with defervescence before treatment 5\.Patients given steroids within 28 days before treatment 6\.Patients given IVIG within 180 days before treatment 7\.Patients with severe underlining diseases 8\.Patients with bacterial infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A study on the anti-inflammatory effects of azithromycin in tuberculosisEUCTR2017-001929-40-NLniversity Medical Center Groningen24
Recruiting
Phase 2
A prospective, randomized pilot study of the immunomodulatory effects of azithromycin in adults with pulmonary tuberculosisNL-OMON47928niversitair Medisch Centrum Groningen24
Completed
Not Applicable
Trial to study the effect of Curvic® in vaccinated population for COVID-19Vaccinated for COVID-19Infections and InfestationsCOVID-19 (SARS-CoV-2 infection)ISRCTN26285740Shreepad Shree Vallabh SSV Phytopharmaceuticals50
Completed
Not Applicable
A randomized controlled trial of immune-enhancing enteral feeding on immunologic and nutritional status in tube-fed patientsmalnutritionJPRN-UMIN000001326Morinaga Milk Industry Co., Ltd.126
Completed
Phase 1
Seasonal influenza vaccine study to determine the effect of an adjuvanted 2012 influenza vaccine in adultsPrevention of influenza infectionInfection - Other infectious diseasesPublic Health - Other public healthACTRN12612000709842Vaxine Pty Ltd200